Literature DB >> 19437576

Scirrhous hepatocellular carcinoma displaying atypical findings on imaging studies.

Soo-Ryang Kim1, Susumu Imoto, Taisuke Nakajima, Kenji Ando, Keiji Mita, Katsumi Fukuda, Ryo Nishikawa, Yu Koma, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.   

Abstract

We describe a 15-mm scirrhous hepatocellular carcinoma (HCC) in a 60-year-old man with B-type cirrhosis. Ultrasound disclosed a 15-mm hypoechoic nodule in segment 7. Contrast-enhanced US revealed heterogeneous, not diffuse, hypervascularity in the early phase and a defect in the Kupffer phase. Contrast-enhanced computed tomography (CT) revealed a heterogeneous hypervascular nodule in the early phase and a low-density area in the late phase. Magnetic resonance imaging (MRI) revealed iso- to hypointensity at T1 and high intensity at T2-weighted sequences. Contrast-enhanced MRI also revealed a heterogeneous hypervascular nodule in the early phase and washout in the late phase. Super-paramagnetic iron oxide-MRI revealed a hyperintense nodule. CT during hepatic arteriography and CT during arterial portography revealed heterogeneous hyperattenuation and a perfusion defect, respectively. Based on these imaging findings the nodule was diagnosed as a mixed well-differentiated and moderately-differentiated HCC. Histologically, the nodule was moderately-differentiated HCC characterized by typical cytological and structural atypia with dense fibrosis. Immunohistochemically, the nodule was positive for heterochromatin protein 1 and alpha-smooth muscle actin, and negative for cytokeratin 19. From the above findings, the nodule was diagnosed as scirrhous HCC. Clinicians engaged in hepatology should exercise caution with suspected scirrhous HCC when imaging studies reveal atypical findings, as shown in our case on the basis of chronic liver disease.

Entities:  

Mesh:

Year:  2009        PMID: 19437576      PMCID: PMC2682251          DOI: 10.3748/wjg.15.2296

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  Clinicopathological study of scirrhous hepatocellular carcinoma.

Authors:  Mina Kurogi; Osamu Nakashima; Hisamitsu Miyaaki; Masaru Fujimoto; Masamichi Kojiro
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

2.  Sclerosing hepatic carcinoma: relationship to hypercalcemia.

Authors:  M Omata; R L Peters; D Tatter
Journal:  Liver       Date:  1981-03

3.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

4.  Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature.

Authors:  M A Berman; J A Burnham; D G Sheahan
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

  4 in total
  2 in total

1.  Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinoma.

Authors:  Jin Hee Lee; Moon Seok Choi; Geum Yeon Gwak; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Dongil Choi; Cheol Keun Park
Journal:  Dig Dis Sci       Date:  2012-02-11       Impact factor: 3.199

2.  Primary hepatic cancers with multiple pathologic features in a patient with hepatitis C: report of a case.

Authors:  Go Oshima; Masahiro Shinoda; Minoru Tanabe; Yohei Masugi; Akihisa Ueno; Kiminori Takano; Minoru Kitago; Osamu Itano; Shigeyuki Kawachi; Kentaro Ohara; Masaya Oda; Akihiro Tanimoto; Michiie Sakamaoto; Yuko Kitagawa
Journal:  Int Surg       Date:  2012 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.